PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Immunology, Amsterdam University Medical Centers (UMC) and Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, The Netherlands.\', \'Department of Pathology, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.\', \'Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands.\', \'Department of Intensive Care and Center for Experimental Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.\', \'Laboratory Genetic Metabolic Diseases, Core Facility Metabolomics, Department of Clinical Chemistry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.\', \'Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/path.5842
?:doi
?:hasPublicationType
?:journal
  • The Journal of pathology
is ?:pmid of
?:pmid
?:pmid
  • 34859884
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34859884>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34859884>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all